Priovant’s Brepocitinib Poised to Address Steroid-Sparing Gap in Dermatomyositis as Rheumatologists Anticipate 2026 Launch
Priovant's Brepocitinib Poised to Address Steroid-Sparing Gap in Dermatomyositis as Rheumatologists Anticipate 2026 Launch Physician sentiment captured in Spherix Global Insights' research highlights high expectations for dual TYK2/JAK1 inhibition, with continued unmet needs across the broader IIM spectrum. GlobeNewswire October 10, 2025 EXTON, PA, Oct. 10, 2025 (GLOBE NEWSWIRE) — Rheumatologists are eagerly anticipating the […]